Showing results (1-10 of 122) with videos related to
Sort By:
Pageof 13
JPMA. the Journal of the Pakistan Medical Association|December 30, 2004
Thymosin alpha 1 in combination with interferon alpha and ribavirin in chronic hepatitis C patients who are non-responders or relapsers to interferon alpha plus ribavirinZ Abbas, S S Hamid, S Tabassum, et al.Singapore Medical Journal|January 25, 2007
Mucormycosis in patients with complicated cirrhosisZ Abbas, W Jafri, S Rasool, et al.British Journal of Biomedical Science|May 8, 2012
Virulence markers of Helicobacter pylori in patients with diarrhoea-dominant irritable bowel syndromeJ Yakoob, Z Abbas, S Naz, et al.British Journal of Biomedical Science|February 8, 2011
Antibiotic susceptibility patterns of Helicobacter pylori and triple therapy in a high-prevalence areaJ Yakoob, S Abid, Z Abbas, et al.JPMA. the Journal of the Pakistan Medical Association|March 6, 1999
Prevalence of Helicobacter pylori antibodies in endoscopy personnel and non-medical volunteers of KarachiZ Abbas, W Jafri, A H Khan, et al.British Journal of Biomedical Science|January 5, 2007
Comparison of biopsy-based methods for the detection of Helicobacter pylori infectionJ Yakoob, S Abid, W Jafri, et al.Epidemiology and Infection|March 15, 2011
Entamoeba species associated with chronic diarrhoea in PakistanJ Yakoob, Z Abbas, M A Beg, et al.Tropical Gastroenterology : Official Journal of the Digestive Diseases Foundation|March 28, 2009
Prevalence and mode of spread of hepatitis B and C in rural Sindh, PakistanZ Abbas, N L Jeswani, G N Kakepoto, et al.British Journal of Biomedical Science|October 21, 2009
Low prevalence of the intact cag pathogenicity island in clinical isolates of Helicobacter pylori in Karachi, PakistanJ Yakoob, W Jafri, Z Abbas, et al.Epidemiology and Infection|June 8, 2010
Risk factors associated with Helicobacter pylori infection treatment failure in a high prevalence areaJ Yakoob, W Jafri, Z Abbas, et al.Pageof 13